Current pathogenetic and molecular concepts in viral liver carcinogenesis

Area of Science:

• Hepatology and Oncology
• Molecular Biology
• Viral Hepatitis Research

Background:

• Hepatocellular carcinoma (HCC) is a major global malignancy, frequently linked to chronic Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections.
• HCC development is a multistep process involving genetic alterations in preneoplastic lesions.
• Understanding the molecular mechanisms of viral hepatitis in hepatocarcinogenesis is crucial.

Purpose of the Study:

• To elucidate the molecular pathways and genetic events driving Hepatocellular carcinoma (HCC) development.
• To investigate the role of viral factors, particularly Hepatitis B Virus (HBV), in hepatocarcinogenesis.
• To provide insights into the interaction of genetic events and growth factor signaling in HCC progression.

Main Methods:

• Analysis of genetic events in preneoplastic lesions associated with HCC.
• Investigation of protooncogene activation and tumor suppressor gene inactivation.
• Study of growth factor expression and signaling pathways in hepatocarcinogenesis.
• Examination of the molecular biology of Hepatitis B Virus (HBV) and its impact on liver cancer.

Main Results:

• Identified stepwise genetic alterations in preneoplastic lesions contributing to HCC formation.
• Demonstrated the significance of protooncogene activation and tumor suppressor gene inactivation.
• Highlighted the role of altered growth factor signaling in HCC progression.
• Revealed key molecular effects of Hepatitis B Virus (HBV) in inducing and advancing liver cancer.

Conclusions:

• Hepatocellular carcinoma (HCC) development is a complex process driven by accumulated genetic events.
• Chronic viral hepatitis, especially HBV, plays a significant role in initiating and progressing HCC.
• Further research into molecular pathways can improve understanding and treatment of HCC.